Lemtrada hasn’t proven to help against disability in the treatment of relapsing multiple sclerosis, said U.S. advisers who questioned whether the company’s studies were conducted well enough to assess the drug.
While the U.S. Food and Drug Administration advisory panel decided that potential safety risks don’t preclude approval of Lemtrada, its members voted 14-2 that the drug didn’t help improve a patient’s disability. The agency isn’t required to accept the recommendations of its advisers..... Read More - http://www.ms-uk.org/lemtrada
MS drug Lemtrada does not benefit patients, FDA panel says
MS drug Lemtrada does not benefit patients, FDA panel says
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 997 Views
-
Last post by NHE
-
- 0 Replies
- 778 Views
-
Last post by ElliotB
-
- 0 Replies
- 1466 Views
-
Last post by CureIous
-
- 0 Replies
- 1428 Views
-
Last post by frodo
-
- 0 Replies
- 1459 Views
-
Last post by NHE
-
- 0 Replies
- 465 Views
-
Last post by NHE
-
- 0 Replies
- 1427 Views
-
Last post by NHE
-
- 1 Replies
- 2898 Views
-
Last post by Tif
-
- 0 Replies
- 2233 Views
-
Last post by frodo